Array BioPharma Reports Financial Results for the Third Quarter of Fiscal 2019

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. LVS
7. SAP
8. CSX
9. LRCX
10. MRK

Go back to Array BioPharma Reports Financial Results for the Third Quarter of Fiscal 2019

Array BioPharma (ARRY) PT Raised to $36 at Guggenheim

May 7, 2019 12:49 PM EDT

Guggenheim analyst Michael Schmidt raised the price target on Array BioPharma (NASDAQ: ARRY) to $36.00 (from $35.00) while maintaining a Buy rating.

strong sales indicated additional upside potential in Melanoma... More

Array Biopharma (ARRY) Tops Q3 EPS by 3c

May 7, 2019 8:04 AM EDT

Array Biopharma (NASDAQ: ARRY) reported Q3 EPS of ($0.17), $0.03 better than the analyst estimate of ($0.20). Revenue for the quarter came in at $64.7 million versus the consensus estimate of $54.04 million.

For earnings history and earnings-related data on Array Biopharma (ARRY) click here.

... More